focus -WSS

focus

author：comprehensive 2025-10-01 13:53:24 - browse：65

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Humana’s losses in Medicare Advantage tank its stock

WSS

Why you shouldn’t ask, “What country has the best health care?”

ProMED, early warning system on disease outbreaks, in peril

What Mike Pence has said that could be used in a Donald Trump trial

Venture capital firm's plans to take over Akron hospital face hurdles

My superpower is killing ticks

OTC birth control: A brief history of over the counter pill design

hotspot

focus

hotspot

Walensky prepares to leave CDC — and Congress — behind

ER docs worry over extreme heat as a 'mass casualty event'

New air purifier tech could be key to improving indoor air quality

Pancreatic cancer early detection could be helped by AI

Drug repurposing or repositioning? The language matters

The drug industry sees a key ally in the Senate prevail

Medicare proposal to cover medical devices draws a mixed reaction

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

New air purifier tech could be key to improving indoor air quality

For BCIs, commercial hurdles may be bigger than scientific ones

entertainment

Boston competes with Raleigh

Biden calls for immediate release of Niger's president amid apparent coup

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Health Care Service Corp to buy Cigna Medicare Advantage plans

The drug industry sees a key ally in the Senate prevail

The Affordable Care Act has saved billions in health care costs

Wikipedia

hotspot

entertainment

hotspot